ivabradine
Selected indexed studies
- Ivabradine for treatment of heart failure. (Expert Opin Drug Saf, 2019) [PMID:31074301]
- Ivabradine in Cardiovascular Disease Management Revisited: a Review. (Cardiovasc Drugs Ther, 2021) [PMID:33411112]
- Ivabradine as adjuvant treatment for chronic heart failure. (Cochrane Database Syst Rev, 2020) [PMID:33147368]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Ivabradine for treatment of heart failure. (2019) pubmed
- Ivabradine in Cardiovascular Disease Management Revisited: a Review. (2021) pubmed
- Ivabradine as adjuvant treatment for chronic heart failure. (2020) pubmed
- Randomized Trial of Ivabradine in Patients With Hyperadrenergic Postural Orthostatic Tachycardia Syndrome. (2021) pubmed
- Ivabradine for the Treatment of Cardiovascular Diseases. (2019) pubmed
- Ivabradine and Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials. (2022) pubmed
- Ivabradine and endothelium: an update. (2020) pubmed
- Ivabradine use in critical care: a systematic review and metanalysis of cardiogenic and septic shock patients. (2025) pubmed
- Does Ivabradine Decrease Cardiovascular Deaths in Heart Failure Patients? (2020) pubmed
- Ivabradine: cardiovascular effects. (2009) pubmed